Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,937,555 | reported | |
| FY 2024 | 2024-12-31 | $6,929,571 | reported | |
| FY 2023 | 2023-12-31 | $7,754,905 | reported | |
| FY 2022 | 2022-12-31 | $7,020,258 | reported | |
| FY 2021 | 2021-12-31 | $5,114,489 | reported | |
| FY 2020 | 2020-12-31 | $2,836,782 | reported | |
| FY 2019 | 2019-12-31 | $2,267,528 | reported | |
| FY 2018 | 2018-12-31 | $4,044,542 | reported | |
| FY 2017 | 2017-12-31 | $6,302,984 | reported | |
| FY 2016 | 2016-12-31 | $2,975,756 | reported | |
| FY 2015 | 2015-12-31 | $5,261,225 | reported | |
| FY 2014 | 2014-12-31 | $4,005,856 | reported |
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR
Twelve months to Sep 30, 2026 · derived
Bio Key International Inc is the 194th largest of the 276 covered companies the SEC files under this code, by revenue. SIC 7372
Latest filing Nov 20, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
7 managers · Quarter ended Sep 30, 2026All holders ›
2BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe;
1 transaction